Bacteriophage therapy

Annual Review of Microbiology

Volumn 55, Issue , 2001, Pages 437-451

  Summers, W C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

d'Herelle; Dysentery; Infection; Prophylaxis; Resistance

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; BACTERIOPHAGE; CHOLERA; CLINICAL TRIAL; DYSENTERY; HUMAN; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

ANIMALS; BACTERIAL INFECTIONS; BACTERIOPHAGES; CLINICAL TRIALS; HUMANS; THERAPEUTIC EQUIVALENCY;

ANIMALIA; UNIDENTIFIED BACTERIOPHAGE;

EID: 0034769921     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.55.1.437     Document Type: Review

References (70)

1. Bacteriophages show promise as antimicrobial agents
2. Editorial. Phage therapy
3. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves
4. Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential
5. Treatment of recurrent furunculosis with staphylococcal bacteriophage-lysed vaccine
6. Phage therapy: Past history and future prospects
7. Bacteriophage treatment of suppurative skin infections
8. Investigation of the effect of brucella-phage on the course of experimental infection with Brucella abortus
9. Sur un microbe invisible antagoniste des bacilles dysentériques
10. Essai de traîtement de la peste bubonique par le bactériophage
11. Sur la vaccination antibarbonique par virus atténué
12. Studies on Asiatic cholera
13. Bacteriophage therapy
14. Who discovered bacteriophage?
15. Bacteriophage therapy
16. The growth of bacteriophage
17. Inability of a bacteriophage pool to control beef spoilage
18. Traitement d'une endocardite a Serratia par les bacteriophages
19. Recherches expérimentale sur la vaccination préventive contre le bacille dysentérique de Shiga
20. Immunogenic effect of bacteriophage in patients subjected to phage therapy
21. Bacteriophages et chirurgie orthopedique. A propos de sept cas
22. Replica plating and indirect selection of bacterial mutants
23. Recherches sur la taille et la structure du bactériophage φp.X.174: Ultracentrifugation
24. Bacteriophage treatment trials on staphylococcal udder infection in lactating cows
25. Phage therapy revisited: The population biology of a bacterial infection and its treatment with bacteriophage and antibiotics
26. Mutations of bacteria from virus sensitivity to virus resistance
27. Clinical studies of the use of bacteriophage in the treatment of cholera
28. Investigation on the therapeutical efficiency of some adapted bacteriophages in experimental infection with Pseudomonas aeruginosa
29. Long-circulating bacteriophage as antibacterial agents
30. Effect of massive doses of bacteriophage on excretion of vibrio, duration of diarrhoea and output of stools in acute cases of cholera
31. Use of a new phage preparation in prophylaxis and treatment of shigellosis
32. Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail
33. Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control
34. Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals
35. Ein beitrag zur behandlung der akuten hamatogenen und chronischen sekundaren osteomyelitiden bei kindern
36. The good virus
37. Characteristics and diffusion in the rabbit of a phage for Escherichia coli O103. Attempts to use this phage for therapy
38. Die sichtbarmachung der bakteriophagen lyse im ubermikroskop
39. Zur frage der chemischen zusammensetzung des bakteriophagen
40. Phage treatment of severe burns
41. Results of bacteriophage treatment of suppurative bacterial infections. III. Detailed evaluation of the results obtained in further 150 cases
42. Results of bacteriophage treatment of suppurative bacterial infections. I. General evaluation of the results
43. Results of bacteriophage treatment of suppurative bacterial infections. II. Detailed evaluation of the results
44. Results of bacteriophage treatment of suppurative bacterial infections. IV. Evaluation of the results obtained in 370 cases
45. Results of bacteriophage treatment of suppurative bacterial infections. V. Evaluation of the results obtained in children
46. Results of bacteriophage treatment of suppurative bacterial infections. VI. Analysis of treatment of suppurative staphylococcal infections
47. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986
48. Treatment of experimental infections of mice with bacteriophages
49. Plague and cholera in India: The bacteriophage inquiry of 1928-1936
50. The construction of bacteriophage as bacterial virus: Linking endogenous and exogenous thought styles
51. Donnees actueles sur les applications therapeutiques des bacteriophages
52. Studies on bacteriophage penetration in patients subjected to phage therapy
53. Effective phage therapy is associated with normalization of cytokine production by blood cell cultures
54. Successful treatment of experimental Escherichia coli infections in mice using phage: Its general superiority over antibiotics
55. Effectiveness of phages in treating experimental Escherichia coli diarrhoea in calves, piglets and lambs
56. Factors influencing the survival and multiplication of bacteriophages in calves and their environment
57. The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages
58. Bacteriophage therapy in infective childhood asthma
59. L'utilisation du bacteriophage dans la prophylaxie et le traitement de la dysenterie bacillaire
60. Considerations sur le traitement des infections urinaires par l'association bacteriophage-autovaccin-antibiotiques